Other Article RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- A whole new world of friends: The Influence of Instant Messenger on Peer Relations
- A Young Researcher Tackles the De Republica
- Abandoning the Promise
- Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy.
- Above all, a Christian witness
- Absolute PSA value is powerful predictor of survival after androgen deprivation: Comment
- Abstract SS02-02: A long walk from FGFR2 alternative splicing to cancer progression
- Accepting Syrian Refugees both Humanitarian and in Our National Interest
- Accident," "Beginning
- Achieving Widespread Availability of Timely and Efficient COVID-19 Testing
- Acknowledging the Public Role in Private Drug Development: Lessons From Remdesivir
- ACT and antithrombin effects
- Acting Like Americans on Ramadan
- Activated clotting time measurements and aprotinin studies.
- Activated clotting times, heparin responses, and antithrombin: have we been wrong all these years?
- Activated recombinant factor VII in cardiac surgery
- Activation of pp60(c-src) is necessary for human vascular smooth muscle cell migration - Discussion
- Active chemotherapy for metastatic stromal cell tumor of the testis.
- Active surveillance for African-American men with prostate cancer: of course! Pro.
- Activity, audit and accountability.
- ACUTE HEMATOCRIT CHANGES IN CAPILLARIES OF STRIATED-MUSCLE DURING FUNCTIONAL HYPEREMIA
- Adaptation as a Philosophical Question
- Adelante el pasado: oralidad y visualidad, acto y evento en la prácticas artísticas del mundo indígena contemporáneo
- Adelita: Enrique Chagoya's Recast Heroine
- Adenosine and thrombolytic therapy in acute myocardial infarction (Abstract)
- Adjustment Reactions and the Surgical Intern
- Adjuvant radiotherapy averts biochemical progression
- Adjuvant radiotherapy linked to better cause-specific survival: Commentary
- Adjuvant radiotherapy remains rare in prostate cancer care: Commentary